These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Generic drugs: bioequivalence and bioavailability. Ansbacher R JAMA; 1988 Jan; 259(2):220. PubMed ID: 2826829 [No Abstract] [Full Text] [Related]
6. The pharmacokinetics and efficacy of different estrogens are not equivalent. Ansbacher R Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470 [TBL] [Abstract][Full Text] [Related]
8. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs. Kefalas CH; Ciociola AA Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264 [No Abstract] [Full Text] [Related]
9. FDA cites new data in decision to bar generic conjugated estrogens. Miller JL Am J Health Syst Pharm; 1997 Jun; 54(12):1376-81. PubMed ID: 9194977 [No Abstract] [Full Text] [Related]
10. A new conjugated estrogen. Med Lett Drugs Ther; 1999 Jul; 41(1058):67-8. PubMed ID: 10445019 [No Abstract] [Full Text] [Related]
11. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh. Basile EM; Tolomeo D; Gluck E Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744 [TBL] [Abstract][Full Text] [Related]
13. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment. Roller ST; Pippins RR; Ngai JW Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646 [TBL] [Abstract][Full Text] [Related]
14. What you should know about estrogens. Or the perils of Pauline. Landau RL JAMA; 1979 Jan; 241(1):47-51. PubMed ID: 214587 [No Abstract] [Full Text] [Related]
15. The bootstrap procedure in individual bioequivalence. Shao J; Chow SC; Wang B Stat Med; 2000 Oct; 19(20):2741-54. PubMed ID: 11033572 [TBL] [Abstract][Full Text] [Related]